BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25822291)

  • 1. Primary definitive radiotherapy with or without chemotherapy for squamous cell carcinoma of the temporal bone.
    Kitani Y; Kubota A; Furukawa M; Sato K; Nakayama Y; Nonaka T; Mizoguchi N
    Eur Arch Otorhinolaryngol; 2016 May; 273(5):1293-8. PubMed ID: 25822291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy.
    Mourad WF; Hu KS; Puckett L; Hauerstock D; Shourbaji RA; Li Z; Manolidis S; Schantz S; Tran T; Jacobson A; Urken M; Culliney B; Persky M; Harrison LB
    Am J Clin Oncol; 2014 Feb; 37(1):57-62. PubMed ID: 23357967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
    Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
    J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple-modality treatment in patients with advanced stage tonsil cancer.
    Roden DF; Schreiber D; Givi B
    Cancer; 2017 Sep; 123(17):3269-3276. PubMed ID: 28440876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can concurrent chemoradiotherapy replace surgery and postoperative radiation for locally advanced stage III/IV tonsillar squamous cell carcinoma?
    Park G; Lee SW; Kim SY; Nam SY; Choi SH; Kim SB; Roh JL; Yoon DH; Kim SS; Park JH; Kim YS; Yoon SM; Song SY; Kim JH; Choi EK; DO Ahn S
    Anticancer Res; 2013 Mar; 33(3):1237-43. PubMed ID: 23482808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
    Zhang MQ; Liu SP; Wang XE
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
    Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK
    Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Zhang J; Chen S; Li G; Zhang W; Qin T; Yin P; Huang H; Jiang H
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1087-1097. PubMed ID: 28429051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy.
    Taguchi T; Nishimura G; Takahashi M; Komatsu M; Sano D; Sakuma N; Arai Y; Yamashita Y; Shiono O; Hirama M; Sakuma Y; Ishitoya J; Hata M; Ogino I; Oridate N
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):837-43. PubMed ID: 23959463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the clinicopathological features of squamous cell carcinoma of the vulva: a retrospective survey of the Tohoku Gynecologic Cancer Unit.
    Futagami M; Yokoyama Y; Iino K; Aoki M; Shoji T; Sugiyama T; Ariga H; Tokunaga H; Takano T; Watanabe Y; Yaegashi N; Jingu K; Sato N; Terada Y; Anbai A; Ohta T; Kurachi H; Kuroda Y; Nishiyama H; Fujimori K; Watanabe T; Sato H; Tase T; Wada H; Mizunuma H
    Int J Clin Oncol; 2015 Oct; 20(5):1005-11. PubMed ID: 25708593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definitive radiotherapy for early-stage hypopharyngeal squamous cell carcinoma.
    Sato K; Kubota A; Furukawa M; Kitani Y; Nakayama Y; Nonaka T; Mizoguchi N; Shiomi M
    Eur Arch Otorhinolaryngol; 2015 Aug; 272(8):2001-6. PubMed ID: 24939176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concurrent chemoradiotherapy followed by consolidation chemotherapy and sequential chemoradiotherapy for stage III non-small cell lung cancer: comparison in 93 patients].
    Sun WZ; Song LP; Zhang YB; Ai T; Lu JL; Ren J; Gao Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):362-7. PubMed ID: 22445984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcome of advance staged oral cavity cancer: concurrent chemoradiotherapy compared with primary surgery.
    Tangthongkum M; Kirtsreesakul V; Supanimitjaroenporn P; Leelasawatsuk P
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2567-2572. PubMed ID: 28321535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy, and/or chemotherapy in stage III and IV maxillary sinus cancer: multi-institutional retrospective analysis.
    Kang JH; Cho SH; Kim JP; Kang KM; Cho KS; Kim W; Seol YM; Lee S; Park HS; Hur WJ; Choi YJ; Oh SY
    J Oral Maxillofac Surg; 2012 Jul; 70(7):1717-23. PubMed ID: 21945430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cell carcinoma of temporal bone: reported on 33 patients.
    Zhang B; Tu G; Xu G; Tang P; Hu Y
    Head Neck; 1999 Aug; 21(5):461-6. PubMed ID: 10402528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.
    Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K
    Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a benefit in receiving concurrent chemoradiotherapy for elderly patients with inoperable thoracic esophageal squamous cell carcinoma?
    Zhang P; Xi M; Zhao L; Shen JX; Li QQ; He LR; Liu SL; Liu MZ
    PLoS One; 2014; 9(8):e105270. PubMed ID: 25133495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
    Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined-modality treatment for advanced oral tongue squamous cell carcinoma.
    Fan KH; Lin CY; Kang CJ; Huang SF; Wang HM; Chen EY; Chen IH; Liao CT; Cheng AJ; Chang JT
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):453-61. PubMed ID: 17236967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.